Woodline Partners LP - ORCHARD THERAPEUTICS PLC ownership

ORCHARD THERAPEUTICS PLC's ticker is ORTX and the CUSIP is 68570P101. A total of 1 filers reported holding ORCHARD THERAPEUTICS PLC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Woodline Partners LP ownership history of ORCHARD THERAPEUTICS PLC
ValueSharesWeighting
Q4 2021$477,000
-42.7%
361,7360.0%0.01%
-50.0%
Q3 2021$832,000
+103.4%
361,736
+542.5%
0.01%
+55.6%
Q1 2021$409,000
-87.1%
56,297
-92.3%
0.01%
-89.3%
Q4 2020$3,177,000
+363.1%
735,455
+340.6%
0.08%
+281.8%
Q3 2020$686,000
-60.9%
166,909
-42.9%
0.02%
-68.1%
Q2 2020$1,754,000
-60.6%
292,250
-50.6%
0.07%
-78.3%
Q1 2020$4,452,000
+187.2%
591,250
+424.4%
0.32%
+404.8%
Q4 2019$1,550,000112,7560.06%
Other shareholders
ORCHARD THERAPEUTICS PLC shareholders Q3 2023
NameSharesValueWeighting ↓
CHI Advisors LLC 5,307,751$3,101,0001.18%
TANG CAPITAL MANAGEMENT LLC 2,000,000$1,168,0000.18%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 6,949,416$4,060,0000.08%
Artal Group S.A. 1,803,858$1,054,0000.06%
GSA CAPITAL PARTNERS LLP 616,402$360,0000.05%
RA Capital Management 3,040,885$1,776,0000.05%
Forefront Analytics, LLC 92,641$58,0000.03%
Temasek Holdings (Private) Ltd 4,319,049$2,523,1880.01%
FEDERATED HERMES, INC. 8,309,859$4,853,0000.01%
Cormorant Asset Management, LP 256,649$150,0000.01%
View complete list of ORCHARD THERAPEUTICS PLC shareholders